This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, United Kingdom
The drug REKAMBYS contains one active pharmaceutical ingredient (API):
1
Rilpivirine
UNII FI96A8X663 - RILPIVIRINE
|
Rilpivirine is a diarylpyrimidine NNRTI of HIV-1. Rilpivirine activity is mediated by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Rilpivirine does not inhibit the human cellular DNA polymerases α, β and γ. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
REKAMBYS Prolonged-release suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J05AG05 | Rilpivirine | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1835535, 1835546 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 093653 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60150638 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9040 |
Country: IT | Agenzia del Farmaco | Identifier(s): 049280011, 049280023 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6250409A1022, 6250409A2029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1091686, 1091687 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100445800, 100445816 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.